Case number 2017-2268
Shire Development, LLC v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SHIRE DEVELOPMENT, LLC v. MYLAN PHARMACEUTICALS INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| May 14, 2018 | 45 | Mandate issued to the United States District Court for the Middle District of Florida. Costs taxed in the amount of $368.40. Service as of this date by the Clerk of Court. [521381] [SJ] [Entered: 05/14/2018 01:05 PM] (1) |
| Apr 20, 2018 | 44 | Bill of Costs for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 04/20/2018 by email. Objection to Bill of Costs due on 05/04/2018. [515784] [17-2268] [Lance Soderstrom] [Entered: 04/20/2018 04:28 PM] (0) |
| Apr 6, 2018 | 43 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: O'Malley, Circuit Judge; Wallach, Circuit Judge and Hughes, Circuit Judge). [511171] [SJ] [Entered: 04/06/2018 10:14 AM] (5) |
| Apr 5, 2018 | 42 | Submitted after ORAL ARGUMENT by Elizabeth Murphy for Cosmo Technologies Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Nogra Pharma Limited and Deepro Mukerjee for Mylan Pharmaceuticals Inc. and Mylan, Inc. Panel: Judge: O'Malley , Judge: Wallach , Judge: Hughes. [510844] [JAB] [Entered: 04/05/2018 11:19 AM] (0) |
| Mar 15, 2018 | 41 | Response to oral argument order from the Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. designating Elizabeth Murphy as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [505497] [Edgar Haug] [Entered: 03/15/2018 11:54 AM] (0) |
| Mar 15, 2018 | 40 | Response to oral argument order from the Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. designating Deepro R. Mukerjee as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [505432] [Deepro Mukerjee] [Entered: 03/15/2018 10:15 AM] (0) |
| Feb 21, 2018 | 39 | NOTICE OF CALENDARING. Panel: 1804K. Case scheduled Apr 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 03/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [499752] [JAB] [Entered: 02/21/2018 01:01 PM] (0) |
| Nov 16, 2017 | 38 | Notice from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. regarding conflicts with oral argument (January 8, 10-12; February 6-8; and March 5, 12). Service: 11/16/2017 by email. [476355] [Edgar Haug] [Entered: 11/16/2017 05:27 PM] (2) |
| Nov 16, 2017 | 37 | Notice from Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. regarding conflicts with oral argument (February 5-9 or March 5-9 2018). Service: 11/16/2017 by email. [476352] [Deepro Mukerjee] [Entered: 11/16/2017 05:16 PM] (2) |
| Nov 13, 2017 | 36 | 6 paper copies of the Joint Appendix [33] received from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. [474773] [CW] [Entered: 11/13/2017 01:05 PM] (0) |
| Nov 9, 2017 | 35 | Clerk's Note to the File: 6 copies of the Corresponding Appellant's Briefs and Joint Appendix on CD-ROM. [474285] [CW] [Entered: 11/09/2017 11:57 AM] (0) |
| Nov 9, 2017 | 34 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [JAN, FEB, MAR], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 11/16/2017. [474235] [MJL] [Entered: 11/09/2017 10:45 AM] (0) |
| Nov 6, 2017 | 33 | APPENDIX FILED for Cosmo Technologies Limited, Nogra Pharma Limited, et al. [31]. Number of Pages: 579. Service: 11/06/2017 by email. The paper copies of the appendix should be received by the court on or before 11/17/2017. [474232] [MJL] [Entered: 11/09/2017 10:39 AM] (579) |
| Nov 6, 2017 | 32 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/06/2017 by email. [473482] [Deepro Mukerjee] [Entered: 11/06/2017 06:37 PM] (3) |
| Nov 6, 2017 | 31 | TENDERED from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Title: JOINT APPENDIX. Service: 11/06/2017 by email. [473475] [Edgar Haug] [Entered: 11/06/2017 06:17 PM] (579) |
| Nov 6, 2017 | 30 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC, Shire Pharmaceutical Development, Inc. and Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 11/06/2017 by email. [473474] [Edgar Haug] [Entered: 11/06/2017 06:06 PM] (3) |
| Nov 6, 2017 | 29 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 11/06/2017 by email. [473473] [Edgar Haug] [Entered: 11/06/2017 06:05 PM] (3) |
| Nov 6, 2017 | 28 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 11/06/2017 by email. [473471] [Edgar Haug] [Entered: 11/06/2017 06:04 PM] (3) |
| Nov 2, 2017 | 27 | 6 paper copies of the Corrected Reply Brief [26] received from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. [472440] [CW] [Entered: 11/02/2017 12:12 PM] (0) |
| Oct 31, 2017 | 24 | Notice of Correction to the Brief Doc No. [22] for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 10/31/2017 by email. [472068] [Edgar Haug] [Entered: 10/31/2017 05:57 PM] (4) |
| Oct 31, 2017 | 25 | TENDERED from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Title: CORRECTED REPLY BRIEF. Service: 10/31/2017 by email. [472069] [Edgar Haug] [Entered: 10/31/2017 05:59 PM] (37) |
| Oct 31, 2017 | 26 | CORRECTED REPLY BRIEF FILED for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, et al. [25]. Number of Pages: 26. Service: 10/31/2017 by email. The paper copies of the brief should be received by the court on or before 11/08/2017. [472092] [MJL] [Entered: 11/01/2017 08:23 AM] (37) |
| Oct 30, 2017 | 22 | TENDERED from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Title: REPLY BRIEF. Service: 10/30/2017 by email. [471697]. This brief has been corrected. See Doc. No. [26]. [Edgar Haug] [Entered: 10/30/2017 10:10 PM] (0) |
| Oct 30, 2017 | 23 | REPLY BRIEF FILED for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, et al. [22]. Number of Pages: 26. Service: 10/30/2017 by email. The paper copies of the brief should be received by the court on or before 11/07/2017. Appendix is due 11/06/2017. [471782]. This brief has been corrected. See Doc. No. [26]. [MJL] [Entered: 10/31/2017 09:50 AM] (0) |
| Oct 18, 2017 | 21 | 6 paper copies of the Opening Response Brief [20] received from Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. [468765] [CW] [Entered: 10/18/2017 11:00 AM] (0) |
| Oct 16, 2017 | 20 | BRIEF FILED for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc. [19]. Number of Pages: 42. Service: 10/16/2017 by email. The paper copies of the brief should be received by the court on or before 10/24/2017. Appellants' reply brief is due 10/30/2017. [468223] [MJL] [Entered: 10/17/2017 08:18 AM] (55) |
| Oct 16, 2017 | 19 | TENDERED from Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Title: RESPONSE BRIEF. Service: 10/16/2017 by email. [468195] [Deepro Mukerjee] [Entered: 10/16/2017 06:10 PM] (55) |
| Sep 8, 2017 | 18 | 6 paper copies of the Opening Brief [17] received from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc. [459669] [CW] [Entered: 09/08/2017 10:57 AM] (0) |
| Sep 5, 2017 | 17 | BRIEF FILED for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, et al. [16]. Number of Pages: 48. Service: 09/05/2017 by email. The paper copies of the brief should be received by the court on or before 09/14/2017. Appellees' brief is due 10/16/2017. [459205] [MJL] [Entered: 09/07/2017 09:43 AM] (84) |
| Sep 5, 2017 | 16 | TENDERED from Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Title: OPENING BRIEF. Service: 09/05/2017 by email. [458750] [Edgar Haug] [Entered: 09/05/2017 07:05 PM] (84) |
| Sep 1, 2017 | 15 | Entry of appearance for Erika Selli as of counsel for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 09/01/2017 by email. [458239] [Elizabeth Murphy] [Entered: 09/01/2017 11:04 AM] (3) |
| Jul 24, 2017 | 14 | Corrected Certificate of Interest for the Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/24/2017 by email. [448630] [Edgar Haug] [Entered: 07/24/2017 11:47 AM] (4) |
| Jul 24, 2017 | 13 | NOTICE OF DEFICIENCY: The certificate of interest [10] filed by Appellants in 17-2268 is incomplete and therefore cannot be accepted for filing at this time. Item #2 was left blank. You are being afforded the opportunity to correct the deficiency. Please ensure all items are filled out. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [448579] [MJL] [Entered: 07/24/2017 10:32 AM] (0) |
| Jul 24, 2017 | 12 | Amended Entry of appearance for Elizabeth J. Murphy as of counsel for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/24/2017 by email. [448514] [Elizabeth Murphy] [Entered: 07/24/2017 07:18 AM] (2) |
| Jul 21, 2017 | 11 | Notice of intent to file corresponding briefs on CD-ROM for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/21/2017 by email. [448485] [Edgar Haug] [Entered: 07/21/2017 05:39 PM] (3) |
| Jul 21, 2017 | 10 | Certificate of Interest for the Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/21/2017 by email. [448484] [Edgar Haug] [Entered: 07/21/2017 05:38 PM] (0) |
| Jul 21, 2017 | 9 | Docketing Statement for the Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/21/2017 by email. [448483] [Edgar Haug] [Entered: 07/21/2017 05:37 PM] (4) |
| Jul 21, 2017 | 8 | Entry of appearance for Elizabeth J. Murphy as principal counsel for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/21/2017 by email. [448482] [Edgar Haug] [Entered: 07/21/2017 05:36 PM] (2) |
| Jul 21, 2017 | 7 | Entry of appearance for Edgar H. Haug as principal counsel for Appellants Cosmo Technologies Limited, Nogra Pharma Limited, Shire Development, LLC and Shire Pharmaceutical Development, Inc.. Service: 07/21/2017 by email. [448481] [Edgar Haug] [Entered: 07/21/2017 05:35 PM] (2) |
| Jul 21, 2017 | 6 | Notice of intent to file corresponding briefs on CD-ROM for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 07/21/2017 by email. [448471] [Deepro Mukerjee] [Entered: 07/21/2017 05:02 PM] (3) |
| Jul 21, 2017 | 5 | Docketing Statement for the Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 07/21/2017 by email. [448470] [Deepro Mukerjee] [Entered: 07/21/2017 05:01 PM] (5) |
| Jul 21, 2017 | 4 | Certificate of Interest for the Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 07/21/2017 by email. [448469] [Deepro Mukerjee] [Entered: 07/21/2017 04:58 PM] (3) |
| Jul 21, 2017 | 3 | Entry of appearance for Lance A. Soderstrom as of counsel for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 07/21/2017 by email. [448468] [Lance Soderstrom] [Entered: 07/21/2017 04:54 PM] (2) |
| Jul 21, 2017 | 2 | Entry of appearance for Deepro R. Mukerjee as principal counsel for Appellees Mylan Pharmaceuticals Inc. and Mylan, Inc.. Service: 07/21/2017 by email. [448467] [Deepro Mukerjee] [Entered: 07/21/2017 04:50 PM] (2) |
| Jul 7, 2017 | 1 | Appeal docketed. Received: 07/05/2017. [444802]Entry of Appearance due 07/21/2017. Certificate of Interest due 07/21/2017. Docketing Statement due 07/21/2017. Appellants' brief due 09/05/2017. [MJL] [Entered: 07/07/2017 11:53 AM] (109) |
